Global Status of Commercialized Biotech/GM Crops: 2015
This paper is relevant to the impact areas in the following areas:
Crops: | Not Crop-Specific |
Traits: | Not Trait-Specific |
Countries: | Not country-specific |
Regions: | Not region-specific |
Tags: |
Abstract or Summary
Following a remarkable run of 19 years of consecutive growth from 1996 to 2014, with 12 years of double-digit growth, the global hectarage of biotech crops peaked at 181.5 million hectares in 2014, compared with 179.7 million hectares in 2015, equivalent to a net marginal decrease of 1 percent. This change is principally due to an overall decrease in total crop hectarage, associated with low prices for commodity crops in 2015.
Additional highlights from ISAAA’s 2015 report include:
–>Innate™ Generation 1 potatoes, with lower levels of acrylamide, a potential carcinogen, and resistance to bruising. InnateTM Generation 2, approved in 2015, also has late blight resistance. It is noteworthy that the potato is the fourth most important food crop in the world.
–>Arctic® Apples that do not brown when sliced.
–>The first non-transgenic genome-edited crop to be commercialized globally, SU Canola™, was planted in the United States.
–>The first-time approval of a GM animal food product, GM salmon, for human consumption.
Download
Global Status of Commercialized Biotech/GM Crops: 2015 (held on an external server, and so may require additional authentication details)
CropLife International fully acknowledges the source and authors of the publication as detailed above.